Correlation Between Eyenovia and Greenwich Lifesciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eyenovia and Greenwich Lifesciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eyenovia and Greenwich Lifesciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eyenovia and Greenwich Lifesciences, you can compare the effects of market volatilities on Eyenovia and Greenwich Lifesciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eyenovia with a short position of Greenwich Lifesciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eyenovia and Greenwich Lifesciences.

Diversification Opportunities for Eyenovia and Greenwich Lifesciences

0.55
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Eyenovia and Greenwich is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Eyenovia and Greenwich Lifesciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Greenwich Lifesciences and Eyenovia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eyenovia are associated (or correlated) with Greenwich Lifesciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Greenwich Lifesciences has no effect on the direction of Eyenovia i.e., Eyenovia and Greenwich Lifesciences go up and down completely randomly.

Pair Corralation between Eyenovia and Greenwich Lifesciences

Given the investment horizon of 90 days Eyenovia is expected to under-perform the Greenwich Lifesciences. In addition to that, Eyenovia is 4.43 times more volatile than Greenwich Lifesciences. It trades about -0.18 of its total potential returns per unit of risk. Greenwich Lifesciences is currently generating about 0.0 per unit of volatility. If you would invest  1,415  in Greenwich Lifesciences on August 28, 2024 and sell it today you would lose (21.00) from holding Greenwich Lifesciences or give up 1.48% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Eyenovia  vs.  Greenwich Lifesciences

 Performance 
       Timeline  
Eyenovia 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eyenovia has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Greenwich Lifesciences 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Very Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Greenwich Lifesciences are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite fairly strong basic indicators, Greenwich Lifesciences is not utilizing all of its potentials. The recent stock price confusion, may contribute to short-horizon losses for the traders.

Eyenovia and Greenwich Lifesciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eyenovia and Greenwich Lifesciences

The main advantage of trading using opposite Eyenovia and Greenwich Lifesciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eyenovia position performs unexpectedly, Greenwich Lifesciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Greenwich Lifesciences will offset losses from the drop in Greenwich Lifesciences' long position.
The idea behind Eyenovia and Greenwich Lifesciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
CEOs Directory
Screen CEOs from public companies around the world
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities